184 related articles for article (PubMed ID: 20110302)
1. Interaction of herpes simplex virus type 2 (HSV-2) glycoprotein D with the host cell surface is sufficient to induce Chlamydia trachomatis persistence.
Vanover J; Kintner J; Whittimore J; Schoborg RV
Microbiology (Reading); 2010 May; 156(Pt 5):1294-1302. PubMed ID: 20110302
[TBL] [Abstract][Full Text] [Related]
2. An early event in the herpes simplex virus type-2 replication cycle is sufficient to induce Chlamydia trachomatis persistence.
Deka S; Vanover J; Sun J; Kintner J; Whittimore J; Schoborg RV
Cell Microbiol; 2007 Mar; 9(3):725-37. PubMed ID: 17140408
[TBL] [Abstract][Full Text] [Related]
3. Chlamydia trachomatis enters a viable but non-cultivable (persistent) state within herpes simplex virus type 2 (HSV-2) co-infected host cells.
Deka S; Vanover J; Dessus-Babus S; Whittimore J; Howett MK; Wyrick PB; Schoborg RV
Cell Microbiol; 2006 Jan; 8(1):149-62. PubMed ID: 16367874
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus co-infection-induced Chlamydia trachomatis persistence is not mediated by any known persistence inducer or anti-chlamydial pathway.
Vanover J; Sun J; Deka S; Kintner J; Duffourc MM; Schoborg RV
Microbiology (Reading); 2008 Mar; 154(Pt 3):971-978. PubMed ID: 18310043
[TBL] [Abstract][Full Text] [Related]
5. Host nectin-1 is required for efficient Chlamydia trachomatis serovar E development.
Hall JV; Sun J; Slade J; Kintner J; Bambino M; Whittimore J; Schoborg RV
Front Cell Infect Microbiol; 2014; 4():158. PubMed ID: 25414835
[TBL] [Abstract][Full Text] [Related]
6. Chlamydial Pre-Infection Protects from Subsequent Herpes Simplex Virus-2 Challenge in a Murine Vaginal Super-Infection Model.
Slade J; Hall JV; Kintner J; Schoborg RV
PLoS One; 2016; 11(1):e0146186. PubMed ID: 26726882
[TBL] [Abstract][Full Text] [Related]
7. [Mechanisms of Chlamydia trachomatis and herpes simplex virus persistence during viral-bacterial infection].
Bekhalo VA; Sysoliatina EV; Nagurskaia EV
Zh Mikrobiol Epidemiol Immunobiol; 2009; (5):105-10. PubMed ID: 20066779
[TBL] [Abstract][Full Text] [Related]
8. In vitro study of a double infection by herpes simplex virus type 2 and Chlamydia trachomatis.
Chiarini F; Mansi A; Pisani S; Seganti L; Brunori S; Gentile V; Di Silverio F
New Microbiol; 1996 Jul; 19(3):263-6. PubMed ID: 8841043
[TBL] [Abstract][Full Text] [Related]
9. Imbalanced oxidative stress causes chlamydial persistence during non-productive human herpes virus co-infection.
Prusty BK; Böhme L; Bergmann B; Siegl C; Krause E; Mehlitz A; Rudel T
PLoS One; 2012; 7(10):e47427. PubMed ID: 23077614
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
J Virol; 2017 May; 91(9):. PubMed ID: 28228587
[TBL] [Abstract][Full Text] [Related]
11. Porcine epidemic diarrhea virus (PEDV) co-infection induced chlamydial persistence/stress does not require viral replication.
Schoborg RV; Borel N
Front Cell Infect Microbiol; 2014; 4():20. PubMed ID: 24660163
[TBL] [Abstract][Full Text] [Related]
12. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
Mpiga P; Ravaoarinoro M
Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
[TBL] [Abstract][Full Text] [Related]
13. Chlamydia trachomatis persistence in vitro: an overview.
Wyrick PB
J Infect Dis; 2010 Jun; 201 Suppl 2(Suppl 2):S88-95. PubMed ID: 20470046
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the N termini of herpes simplex virus type 1 and 2 gDs alter functional interactions with the entry/fusion receptors HVEM, nectin-2, and 3-O-sulfated heparan sulfate but not with nectin-1.
Yoon M; Zago A; Shukla D; Spear PG
J Virol; 2003 Sep; 77(17):9221-31. PubMed ID: 12915538
[TBL] [Abstract][Full Text] [Related]
15. A Herpes Simplex Virus 2 (HSV-2) gD Mutant Impaired for Neural Tropism Is Superior to an HSV-2 gD Subunit Vaccine To Protect Animals from Challenge with HSV-2.
Wang K; Goodman KN; Li DY; Raffeld M; Chavez M; Cohen JI
J Virol; 2016 Jan; 90(1):562-74. PubMed ID: 26559846
[TBL] [Abstract][Full Text] [Related]
16. Commonly prescribed β-lactam antibiotics induce C. trachomatis persistence/stress in culture at physiologically relevant concentrations.
Kintner J; Lajoie D; Hall J; Whittimore J; Schoborg RV
Front Cell Infect Microbiol; 2014; 4():44. PubMed ID: 24783061
[TBL] [Abstract][Full Text] [Related]
17. A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus.
Du R; Wang L; Xu H; Wang Z; Zhang T; Wang M; Ning Y; Deng F; Hu Z; Wang H; Li Y
Antiviral Res; 2017 Nov; 147():131-141. PubMed ID: 29061442
[TBL] [Abstract][Full Text] [Related]
18. Effects of vaginal lactobacilli in Chlamydia trachomatis infection.
Mastromarino P; Di Pietro M; Schiavoni G; Nardis C; Gentile M; Sessa R
Int J Med Microbiol; 2014 Jul; 304(5-6):654-61. PubMed ID: 24875405
[TBL] [Abstract][Full Text] [Related]
19. Chlamydia trachomatis and herpes simplex virus 2 infection in vulvar intraepithelial neoplasia associated with human papillomavirus.
Kwaśniewska A; Korobowicz E; Visconti J; Zdunek M; Szymańiski M; Goździcka-Józefiak A
Eur J Gynaecol Oncol; 2006; 27(4):405-8. PubMed ID: 17009637
[TBL] [Abstract][Full Text] [Related]
20. Damage/Danger Associated Molecular Patterns (DAMPs) Modulate Chlamydia pecorum and C. trachomatis Serovar E Inclusion Development In Vitro.
Leonard CA; Schoborg RV; Borel N
PLoS One; 2015; 10(8):e0134943. PubMed ID: 26248286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
